AAAAAA

   
Results: 1-25 |
Results: 25
Recombinant DNA vaccines protect against tumors that are resistant to recombinant vaccinia vaccines containing the same gene
Authors: Chen, CH Wang, TL Ji, H Hung, CF Pardoll, DM Cheng, WF Ling, M Wu, TC
Citation: Ch. Chen et al., Recombinant DNA vaccines protect against tumors that are resistant to recombinant vaccinia vaccines containing the same gene, GENE THER, 8(2), 2001, pp. 128-138
Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: A phase I trial of safety and immuneactivation
Authors: Jaffee, EM Hruban, RH Biedrzycki, B Laheru, D Schepers, K Sauter, PR Goemann, M Coleman, J Grochow, L Donehower, RC Lillemoe, KD O'Reilly, S Abrams, RA Pardoll, DM Cameron, JL Yeo, CJ
Citation: Em. Jaffee et al., Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: A phase I trial of safety and immuneactivation, J CL ONCOL, 19(1), 2001, pp. 145-156
Controlled local delivery of interleukin-2 by biodegradable polymers protects animals from experimental brain tumors and liver tumors
Authors: Hanes, J Sills, A Zhao, Z Suh, KW Tyler, B DiMeco, F Brat, DJ Choti, MA Leong, KW Pardoll, DM Brem, H
Citation: J. Hanes et al., Controlled local delivery of interleukin-2 by biodegradable polymers protects animals from experimental brain tumors and liver tumors, PHARM RES, 18(7), 2001, pp. 899-906
Immunology - Stress, NK receptors, and immune surveillance
Authors: Pardoll, DM
Citation: Dm. Pardoll, Immunology - Stress, NK receptors, and immune surveillance, SCIENCE, 294(5542), 2001, pp. 534-536
Antigen-specific blockade of T cells in vivo using dimeric MHC peptide
Authors: O'Herrin, SM Slansky, JE Tang, Q Markiewicz, MA Gajewski, TF Pardoll, DM Schneck, JP Bluestone, JA
Citation: Sm. O'Herrin et al., Antigen-specific blockade of T cells in vivo using dimeric MHC peptide, J IMMUNOL, 167(5), 2001, pp. 2555-2560
An immunodominant MHC class II-restricted tumor antigen is conformation dependent and binds to the endoplasmic reticulum chaperone, calreticulin
Authors: Golgher, D Korangy, F Gao, B Gorski, K Jaffee, E Edidin, M Pardoll, DM Elliott, T
Citation: D. Golgher et al., An immunodominant MHC class II-restricted tumor antigen is conformation dependent and binds to the endoplasmic reticulum chaperone, calreticulin, J IMMUNOL, 167(1), 2001, pp. 147-155
B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells
Authors: Tseng, SY Otsuji, M Gorski, K Huang, X Slansky, JE Pai, SI Shalabi, A Shin, T Pardoll, DM Tsuchiya, H
Citation: Sy. Tseng et al., B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells, J EXP MED, 193(7), 2001, pp. 839-845
Intracranial paracrine interleukin-2 therapy stimulates prolonged antitumor immunity that extends outside the central nervous system
Authors: Ewend, MG Thompson, RC Anderson, R Sills, AK Staveley-O'Carroll, K Tyler, BM Hanes, J Brat, D Thomas, M Jaffee, EM Pardoll, DM Brem, H
Citation: Mg. Ewend et al., Intracranial paracrine interleukin-2 therapy stimulates prolonged antitumor immunity that extends outside the central nervous system, J IMMUNOTH, 23(4), 2000, pp. 438-448
Therapeutic vaccination for cancer
Authors: Pardoll, DM
Citation: Dm. Pardoll, Therapeutic vaccination for cancer, CLIN IMMUNO, 95(1), 2000, pp. S44-S62
Enhanced antigen-specific antitumor immunity with altered peptide ligands that stabilize the MHC-peptide-TCR complex
Authors: Slansky, JE Rattis, FM Boyd, LF Fahmy, T Jaffee, EM Schneck, JP Margulies, DH Pardoll, DM
Citation: Je. Slansky et al., Enhanced antigen-specific antitumor immunity with altered peptide ligands that stabilize the MHC-peptide-TCR complex, IMMUNITY, 13(4), 2000, pp. 529-538
Intramuscular administration of E7-transfected dendritic cells generates the most potent E7-specific anti-tumor immunity
Authors: Wang, TL Ling, M Shih, IM Pham, T Pai, SI Lu, Z Kurman, RJ Pardoll, DM Wu, TC
Citation: Tl. Wang et al., Intramuscular administration of E7-transfected dendritic cells generates the most potent E7-specific anti-tumor immunity, GENE THER, 7(9), 2000, pp. 726-733
Boosting with recombinant vaccinia increases HPV-16 E7-specific T cell precursor frequencies of HPV-16 E7-expressing DNA vaccines
Authors: Chen, CH Wang, TL Hung, CF Pardoll, DM Wu, TC
Citation: Ch. Chen et al., Boosting with recombinant vaccinia increases HPV-16 E7-specific T cell precursor frequencies of HPV-16 E7-expressing DNA vaccines, VACCINE, 18(19), 2000, pp. 2015-2022
Antigen-specific immunotherapy for human papillomavirus 16 E7-expressing tumors grown in the liver
Authors: Chen, CH Suh, KW Ji, HX Choti, MA Pardoll, DM Wu, TC
Citation: Ch. Chen et al., Antigen-specific immunotherapy for human papillomavirus 16 E7-expressing tumors grown in the liver, J HEPATOL, 33(1), 2000, pp. 91-98
Paracrine delivery of IL-12 against intracranial 9L gliosarcoma in rats
Authors: DiMeco, F Rhines, LD Hanes, J Tyler, BM Brat, D Torchiana, E Guarnieri, M Colombo, MP Pardoll, DM Finocchiaro, G Brem, H Olivi, A
Citation: F. Dimeco et al., Paracrine delivery of IL-12 against intracranial 9L gliosarcoma in rats, J NEUROSURG, 92(3), 2000, pp. 419-427
In vivo CD4(+) T cell tolerance induction versus priming is independent ofthe rate and number of cell divisions
Authors: Adler, AJ Huang, CT Yochum, GS Marsh, DW Pardoll, DM
Citation: Aj. Adler et al., In vivo CD4(+) T cell tolerance induction versus priming is independent ofthe rate and number of cell divisions, J IMMUNOL, 164(2), 2000, pp. 649-655
CD40-independent pathways of T cell help for priming of CD8(+) cytotoxic Tlymphocytes
Authors: Lu, ZB Yuan, LX Zhou, XZ Sotomayor, E Levitsky, HI Pardoll, DM
Citation: Zb. Lu et al., CD40-independent pathways of T cell help for priming of CD8(+) cytotoxic Tlymphocytes, J EXP MED, 191(3), 2000, pp. 541-550
Antigen-specific cancer immunotherapy using a GM-CSF secreting allogeneic tumor cell-based vaccine
Authors: Chang, EY Chen, CH Ji, HX Wang, TL Hung, K Lee, BP Huang, AYC Kurman, RJ Pardoll, DM Wu, TC
Citation: Ey. Chang et al., Antigen-specific cancer immunotherapy using a GM-CSF secreting allogeneic tumor cell-based vaccine, INT J CANC, 86(5), 2000, pp. 725-730
Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene
Authors: Chen, CH Wang, TL Hung, CF Yang, YQ Young, RA Pardoll, DM Wu, TC
Citation: Ch. Chen et al., Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene, CANCER RES, 60(4), 2000, pp. 1035-1042
Attrition of T cell memory: Selective loss of LCMV epitope-specific memoryCD8 T cells following infections with heterologous viruses
Authors: Selin, LK Lin, MY Kraemer, KA Pardoll, DM Schneck, JP Varga, SM Santolucito, PA Pinto, AK Welsh, RM
Citation: Lk. Selin et al., Attrition of T cell memory: Selective loss of LCMV epitope-specific memoryCD8 T cells following infections with heterologous viruses, IMMUNITY, 11(6), 1999, pp. 733-742
Targeting human papillomavirus type 16 E7 to the endosomal/lysosomal compartment enhances the antitumor immunity of DNA vaccines against murine humanpapillomavirus type 16 E7-expressing tumors
Authors: Ji, HX Wang, TL Chen, CH Pai, SI Hung, CF Lin, KY Kurman, RJ Pardoll, DM Wu, TC
Citation: Hx. Ji et al., Targeting human papillomavirus type 16 E7 to the endosomal/lysosomal compartment enhances the antitumor immunity of DNA vaccines against murine humanpapillomavirus type 16 E7-expressing tumors, HUM GENE TH, 10(17), 1999, pp. 2727-2740
Gene gun-mediated DNA vaccination induces antitumor immunity against humanpapillomavirus type 16 E7-expressing murine tumor metastases in the liver and lungs
Authors: Chen, CH Ji, H Suh, KW Choti, MA Pardoll, DM Wu, TC
Citation: Ch. Chen et al., Gene gun-mediated DNA vaccination induces antitumor immunity against humanpapillomavirus type 16 E7-expressing murine tumor metastases in the liver and lungs, GENE THER, 6(12), 1999, pp. 1972-1981
Inducing autoimmune disease to treat cancer
Authors: Pardoll, DM
Citation: Dm. Pardoll, Inducing autoimmune disease to treat cancer, P NAS US, 96(10), 1999, pp. 5340-5342
Limitations of adenovirus-mediated interleukin-2 gene therapy for oral cancer
Authors: O'Malley, BW Li, DQ Buckner, A Duan, L Woo, SLC Pardoll, DM
Citation: Bw. O'Malley et al., Limitations of adenovirus-mediated interleukin-2 gene therapy for oral cancer, LARYNGOSCOP, 109(3), 1999, pp. 389-395
Treament of liver metastases from colon carcinoma with autologous tumor vaccine expressing granulocyte-macrophage colony-stimulating factor
Authors: Suh, KW Piantadosi, S Yazdi, HA Pardoll, DM Brem, H Choti, MA
Citation: Kw. Suh et al., Treament of liver metastases from colon carcinoma with autologous tumor vaccine expressing granulocyte-macrophage colony-stimulating factor, J SURG ONC, 72(4), 1999, pp. 218-224
Paracrine immunotherapy with interleukin-2 and local chemotherapy is synergistic in the treatment of experimental brain tumors
Authors: Sampath, P Hanes, J DiMeco, F Tyler, BM Brat, D Pardoll, DM Brem, H
Citation: P. Sampath et al., Paracrine immunotherapy with interleukin-2 and local chemotherapy is synergistic in the treatment of experimental brain tumors, CANCER RES, 59(9), 1999, pp. 2107-2114
Risultati: 1-25 |